Independent medication information Not a pharmacy · Not a substitute for medical advice
Psilocybin mushrooms / Mushroom species

Psilocybe cubensis

Identity, uses and research, side effects, dosage context, pricing and online access.

Mushroom speciesPsilocybin mushrooms
Reference namePsilocybe cubensis
Entry typeMushroom species
CategoryPsilocybin mushrooms
KingdomFungi
GenusPsilocybe
SpeciesPsilocybe cubensis

DrugRX editorial reference · Sources consulted · Not independently medically reviewed

Psilocybe cubensis mushrooms photographed by Mädi

Psilocybe cubensis species illustration: Golden Teacher pictured. This photograph does not identify the variety discussed on this page.

Mädi / Wikimedia Commons · CC BY-SA 3.0

About Psilocybe cubensis

Psilocybe cubensis is a psilocybin-producing mushroom species. Golden Teacher, Penis Envy, Albino Penis Envy and B+ are cultivated names associated with this species, not separate active chemicals.

Also searched as: Cubensis · P. cubensis · cubes

PRICE, COST & AVAILABILITY

Buy Psilocybe cubensis: pricing & legal access

Psilocybe cubensis online: availability & product information

Psilocybin and psilocin are federally controlled in the United States. Product labels and local policy do not establish that consumer delivery is lawful. DrugRX provides no vendor or unverified marketplace price.

Pricing status: No live price feed or verified quote. DrugRX does not sell or dispense products.

Sources: DEA — Controlled substances alphabetical list (October 2026)

DETAILED REFERENCE

Psilocybe cubensis information

Species, varieties and active compounds

Studies analyze psilocybin, psilocin and other tryptamines in P. cubensis. Cultivated names are not equivalent to registered medicine formulations or proof of a fixed chemical profile.

Sources: Controlled study of 14 P. cubensis strains (2026) · Chemical analysis of five P. cubensis strains (2024)

Potency and identification risks

Measured alkaloid composition varies between samples. A photograph, cap shape or variety label cannot establish potency or rule out a dangerous identification error. See the psilocybin guide for general health effects.

Sources: Controlled study of 14 P. cubensis strains (2026) · DEA — Psilocybin

Why no standard mushroom dose is listed

A weight of dried fruiting bodies is not a standardized quantity of psilocybin. This directory does not provide consumption or cultivation instructions.

Sources: Chemical analysis of five P. cubensis strains (2024)

How to read strain comparisons

A laboratory result describes the tested material. It should not be treated as a guarantee for every mushroom sharing that name. The directory preserves varieties as children of the species to keep this distinction visible.

Sources: Controlled study of 14 P. cubensis strains (2026)

Scientific classification

P. cubensis belongs to the fungal order Agaricales and the family Hymenogastraceae in the cited taxonomy record. Cultivated names sit beneath the species context and do not establish separate species-level taxa.

RankName
KingdomFungi
PhylumBasidiomycota
ClassAgaricomycetes
OrderAgaricales
FamilyHymenogastraceae
GenusPsilocybe

Sources: NCBI Taxonomy — Psilocybe cubensis (181762)

Compounds measured in the species

Chemical studies have measured psilocybin, psilocin and minor tryptamines in P. cubensis material. Differences can occur between named strains and individual fruiting bodies; a species identification is not a fixed chemical specification.

Sources: Controlled study of 14 P. cubensis strains (2026)

Identification and laboratory analysis

Taxonomic identification asks which organism is present. Alkaloid analysis asks which chemicals are present and in what amounts. A visual impression or a cultivated label does not answer both questions.

Sources: Controlled study of 14 P. cubensis strains (2026) · NCBI Taxonomy — Psilocybe cubensis (181762)

Using the variety directory

Golden Teacher, Penis Envy, B+ and Albino Penis Envy have separate pages to explain naming and available evidence. They remain connected to this species page so a cultivated name is not mistaken for a different active chemical.

Sources: P. cubensis genetics and research gaps (2025)

Sources and editorial notes

Prepared by DrugRX using the references linked below. Sources were consulted on 2026-10-31. This page has not been independently reviewed by a clinician. Research findings, medication approval and legal permission are separate questions.

  1. Controlled study of 14 P. cubensis strains (2026)
  2. Chemical analysis of five P. cubensis strains (2024)
  3. DEA — Psilocybin
  4. NCBI Taxonomy — Psilocybe cubensis (181762)
  5. P. cubensis genetics and research gaps (2025)
  6. DEA — Controlled substances alphabetical list (October 2026)

Legal information is a dated U.S. reference. Product rules and local laws may change. Where the evidence does not establish a dose, interaction profile or price, the page states that limitation.